Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 5.7B | 5.6B | 5.4B | 5.5B |
Cost of revenue | 4.2B | 4.2B | 4.0B | 4.2B |
Gross profit | 1.4B | 1.4B | 1.4B | 1.2B |
Operating expense | ||||
Research & development | 140M | 177M | 170M | 155M |
Selling general and admin | 643M | 733M | 701M | 803M |
Other operating expenses | — | — | — | — |
Operating income | 687M | 469M | 492M | 265M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 611M | 401M | 415M | 158M |
Tax provision | 140M | 130M | 96M | 170M |
Net income | 244M | 238M | 344M | -575M |
Basic EPS | 0.4 | — | 0.6 | -0.7 |
Diluted EPS | 0.4 | — | 0.6 | -0.7 |
Basic average shares | 563.2M | — | 562.1M | 565.2M |
Diluted average shares | 563.2M | — | 562.1M | 565.2M |
EBITDA | 949M | 948M | 757M | 609M |
Net income from continuing op. | 471M | 271M | 319M | -45M |
Minority interests | -15M | 2M | -18M | 202M |
Preferred stock dividends | 0 | 0 | 0 | 0 |